A new species of microsporidian, Septata intestinalis, was recently recognized as an opportunistic pathogen of AIDS patients. In this study, it was cultured from the nasopharyngeal aspirate of a human immunodeficiency virus type 1-infected patient with disseminated microsporidiosis. In human embryonic lung cells exposed to S. intestinalis, a cytopathic effect appeared within 28 days as foci of rounded up cells. Thin-section electron microscopy showed a variety of developmental stages of the microsporidium within parasitophorous vacuoles. In monocyte-derived macrophages, evidence of infection and development of the parasite was demonstrated by light and electron microscopy. In both infected human embryonic lung cells and monocyte-derived macrophages, a network of septa separated individual spores. Partial sequencing of the RNA small-subunit gene (16S rDNA gene) confirmed the identity of this parasite as S. intestinalis. This is the first report of the isolation of S. intestinalis in vitro and provides evidence that the parasite can be disseminated by macrophages.
Microsporidia are protozoan parasites which are classified in the phylum Microspora and infect a wide range of hosts, including humans (4) . They are an important opportunistic agent of infection in human immunodeficiency virus (HIV)-infected patients with AIDS or advanced immunosuppression. Microsporidia have been associated with a variety of illnesses including diarrhea (8) , keratoconjunctivitis (13) , myositis (11) , peritonitis (25) , cholangitis (15) , hepatitis (22) , and sinusitis (10) . Disseminated illness has also been reported (14, 18, 24) .
The nature of disseminated microsporidiosis in AIDS patients is not well understood. Although Encephalitozoon hellem has been reported as a cause of disseminated infection (18, 24) , recent studies have proposed that a new species, Septata intestinalis, is also associated with this syndrome (5, 19) . Currently, differentiation between these two species is difficult because specific diagnostic tests are unavailable and identification requires visualization of the developing parasite in a host cell. There is also uncertainty as to the mechanism of dissemination. Although it has been postulated that macrophages play a role in this process (5, 14) there has been no conclusive evidence to date that microsporidia can replicate within cells of this lineage.
Recently, some success in the cultivation of human microsporidia has been achieved. Although microsporidia have not been isolated from human feces, there have been reports of the cultural isolation of E. hellem from conjunctival or corneal scrapings (7) and Nosema corneum from corneal tissue (20) .
Recent studies in this laboratory have recognized an Encephalitozoon-or Septata-like species associated with disseminated infection in a patient with advanced HIV infection (17) . The nasopharyngeal aspirate (NPA) from this individual was used as the source material to study the growth characteristics of the parasite in human embryonic lung (HEL) cells and human monocyte-derived macrophages (MDM).
MATERIALS AND METHODS
Origin of material. In October 1992, a 32-year-old HIV-1-infected male presented with nasal stuffiness and clinical features of sinusitis. His CD4 cell count was 10/mm 3 , and Mycobacterium avium complex (MAC) bacteremia had occurred in September 1992 as his AIDS-defining illness. His medication included zidovudine, co-trimoxazole for Pneumocystis carinii pneumonia prophylaxis, and M. avium complex therapy. Sinus X rays revealed opacification of his right and left maxillary sinuses, and he was treated with amoxicillin-clavulanate (500 mg three times a day) and decongestants. One week later, he reported that his nasal stuffiness had improved. In February 1993, the patient presented with a 2-week history of nasal stuffiness and green nasal discharge. He was afebrile and did not have tenderness over the facial sinuses. He was treated with amoxicillin-clavulanate (500 mg three times a day) for 7 days. A swab of the nasal discharge was taken for culture, and trichrome blue staining for microsporidia was also performed (17) . Bacterial and viral cultures were negative, but microsporidia were detected. An NPA was obtained, and staining of a smear by the trichrome blue method (17) revealed microsporidial spores. Subsequent examination of feces and urine by the same procedure showed the presence of spores of similar size and staining characteristics. One month later, the patient reported ongoing nasal stuffiness, epigastric pain, and a 2-week history of diarrhea. A gastroscopy was performed and it revealed candida esophagitis; a biopsy of the duodenum revealed intracytoplasmic microsporidia. Clostridium difficile toxin was isolated from the stool. The patient received a 2-week course of albendazole, 400 mg twice a day, for treatment of the microsporidial infection and commenced fluconazole (200 mg daily) and metronidazole (400 mg three times a day for 10 days) therapy. Four weeks later, the patient reported that his symptoms of nasal stuffiness and sinus discomfort had resolved, and subsequently he experienced only occasional and mild nasal symptoms. Long-term oral vancomycin therapy was subsequently required to control relapsing C. difficile diarrhea. Following the course of albendazole, microsporidial spores were not seen again in the stools. The patient developed pancreatitis in July 1993 secondary to didanosine (ddI) treatment and died in November 1993 following a gradual deterioration in health.
In vitro growth in HEL cells. NPA was inoculated into 6-day-old confluent HEL cells in 75-cm 3 tissue culture flasks (Costar, Cambridge, Mass.). The specimen was allowed to absorb for 2 h at 37ЊC, and the monolayer was then rinsed twice with 30 ml of basal Eagle medium (Flow ICN, Irvine, Scotland) supplemented with 5% fetal calf serum (Commonwealth Serum Laboratories Ltd., Parkville, Victoria, Australia), 100 IU of penicillin per ml, and 100 g of streptomycin (Commonwealth Serum Laboratories Ltd.) per ml. The cells were incubated in this medium for 2 days at 37ЊC and then maintained in 30 ml of basal Eagle medium-2% fetal calf serum with the penicillin and streptomycin, also at 37ЊC. The medium was changed weekly; every 3 to 4 weeks, the medium was removed and infected cells were resuspended with approximately 1 ml of 0.25% trypsin-EDTA (disodium salt) and added to a suspension of fresh uninfected HEL cells. Uninfected HEL cells were similarly cultured as a control.
In vitro growth in MDM. Monocytes were isolated from HIV-seronegative buffy coats (purchased from the Red Cross Blood Bank, Melbourne, Australia) by Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) density gradient centrifuga-tion and plastic adherence, as described previously (6) . Monocytes were cultured in Iscove's medium (Cytosystems, Castle Hill, New South Wales, Australia) supplemented with 10% heat-inactivated human AB-positive serum (generously donated by Red Cross Blood Bank, Sydney, New South Wales, Australia), 2 mM L-glutamine (Flow ICN), 100 IU of penicillin (Flow ICN) per ml, and 100 g of streptomycin (Flow ICN) per ml. Monocytes were cultured in suspension, at 10 6 /ml, using Teflon-coated (polytetrafluorethylene) jars (Savillex). The medium was changed weekly.
Three days postisolation, 2 ϫ 10 7 monocytes were incubated with 200 l of NPA which contained approximately 5 ϫ 10 5 microsporidia per ml. After 2 h of incubation at 37ЊC, macrophage medium was added to maintain a cell concentration of 10 6 /ml. Monocytes from the same donor not exposed to microsporidia were similarly cultured as a control.
Light microscopy. Ten milliliters of the culture fluid harvested from the infected and uninfected HEL cells (day 29 postinfection) and macrophages (days 3, 7, 14, and 21 postinfection) was centrifuged at 4,000 ϫ g for 10 min, and 8.5 ml of the supernatant was removed. Slides were prepared from the deposit by cytocentrifugation at 1,000 ϫ g for 10 min (Shandon Cytospin 3), air dried, fixed in methanol for 10 min, and then stained by the trichrome blue method (17) .
Electron microscopy of HEL cells. Fourteen days after the first subculture (approximately 6 weeks postinfection), infected and uninfected HEL cells were harvested for thin-section electron microscopy (TSEM). Cells were washed in Hanks' basal salt solution and incubated in 0.25% trypsin-EDTA for 5 min at 37ЊC. The resulting cell suspension was centrifuged for 10 min at 2,400 ϫ g. The supernatant was discarded, and the pellet was resuspended in basal Eagle medium-2% fetal calf serum and then centrifuged at 10,700 ϫ g for 2 min. The pellets were processed for TSEM as described by Lee et al. (12) except that cells were embedded in Spurr resin (Ladd Industries, Inc., Burlington, Vt.). Ultrathin sections were stained with uranyl acetate (21) and lead citrate (16) . Sections were examined with a Philips CM12 electron microscope.
Electron microscopy of MDM. On days 3, 7, 14, and 21 postinfection, 10 6 MDM were removed from both the infected and uninfected cultures. The cells were washed with phosphate-buffered saline and centrifuged at 5,500 ϫ g for 3 min. The pellets were then fixed and processed for electron microscopy as described above. 16S rDNA gene sequencing. Purified DNA was extracted from a washed pellet of infected HEL cell supernatant by cell lysis in 1 mg of proteinase K per ml-1% sodium dodecyl sulfate followed by two extractions with phenol-chloroform (50: 50) and ethanol precipitation. The DNA pellet was washed with 70% ethanol, dried, and stored at 4ЊC until reconstitution with sterile water (1). Near-fulllength amplification of the RNA small-subunit gene (16S rDNA gene) was performed as described previously, using primers that are conserved in microsporidial species (26): P1, 5Ј-CAC CAGGTT GAT TCT GCC TGA C-3Ј; P2, 5Ј-GGT TTA CCT TGT TAC GAC TT-3Ј. An amplification product of approximately 1,450 bp was obtained and purified by gel extraction (Wizard PCR Preps purification; Promega, Melbourne, Victoria, Australia). Partial sequencing of the amplified 16S rDNA gene with the P1 and P2 primers (fmol DNA Sequencing System; Promega) obtained 394 of the 1,450 bases for comparison. Analysis of the sequence data was performed by using MacVector software and the February 1994 Entrez database.
RESULTS

In vitro growth of S. intestinalis in HEL cells. (i) Light microscopy.
A cytopathic effect (CPE) was first detected at day 28 in HEL cells inoculated with microsporidia but not in uninfected control cells. The CPE appeared as foci of rounded, nonrefractile cells within the matrix of elongated fibroblastic HEL cells (Fig. 1A and B) . As the CPE progressed, the foci of small round cells became progressively larger.
Trichrome blue staining indicated that spores were plentiful in the supernatant fluid when the CPE was well advanced. Spores appeared as red-staining ovoid structures (2 to 2.5 by 1.0 m) and showed a characteristic vacuole (Fig. 2) . Occasionally, a disrupted cell disgorging large quantities of spores was noted.
(ii) TSEM. Replication of the parasite in infected HEL cells was confirmed by the observation of a variety of developmental Mature spores generally appeared in a longitudinal section as ovoid structures measuring about 1.8 m in length and about 0.9 m in width. They were marked by a distinct internal coiled tube (polar tubule) about 100 nm in diameter. The coil occupied the periphery of the spore interior and commonly showed four to five turns (Fig. 3A) . In a transverse section, the polar tubule was made up of three bands: an inner fuzzy band and two outer membranes (Fig. 3B) . Depending on the plane of section, the spore interior could be seen to contain ribosomes often in regular arrays (Fig. 3C) , an occasional vacuole (Fig. 3D) , and a nucleus (Fig. 3A) . The spore was surrounded by a unit membrane (plasmalemma), which in turn was surrounded by an outer coat. The outer coat was made up of two layers: a lighter inner endospore and a darker, sometimes corrugated, multilayered outer exospore (Fig. 3E) . On some occasions spores with extruded polar tubules were noted. The tubule arose from a bulbous protrusion (anchoring disk) at one end of the spore (Fig. 3F) .
Single nucleated cells in parasitophorous vacuoles in the cytoplasm of the host cell were the earliest recognized stages in the development of the parasite. These forms had a large nucleus/cytoplasm ratio and were in contact with the membrane of the surrounding parasitophorous vacuole. The cytoplasm of these forms showed occasional strands of rough endoplasmic reticulum (Fig. 3A) . The next stage of morphogenesis appeared to involve the formation of a sporont from the early stage. The sporont was characterized by a thickened surrounding plasmalemma and had moved away from the periphery of the enclosing parasitophorous vacuole (Fig. 4A) . Sporonts with more than one nucleus were also seen (Fig. 4B) . In some cases the cytoplasm between the two nuclei was apparently pinching off to form two uninucleate sporonts (Fig.  4B) . Occasionally, maturation of spores took place without complete division of the sporonts so that connected spores were formed (Fig. 4A) .
A striking feature of the parasitophorous vacuole was the presence of zones of material separating individual spores. This septate material was granular in appearance and similar in texture to the cytoplasm of the host cell (Fig. 5) . A distinctive clear area separated the spore from the septate material.
In vitro growth of S. intestinalis in MDM. (i) Light microscopy.
No CPE was evident in the infected MDM culture. A systematic scan of the trichrome blue-stained supernatant preparations was therefore carried out at several intervals to monitor production of spores. No spores were present at days 3 and 7 postinfection. At 14 days, spores identical to those seen in the infected HEL cells were rarely detected; by day 21, spores were commonly observed. In both cases spores tended to be clumped and to be associated with cellular material. The spores measured about 2 to 2.5 by 1.0 m, but there were numerous aberrant forms measuring up to 4.0 by 1.5 m. No microsporidia were detected in control uninfected MDM at day 21.
(ii) TSEM. Specimens were examined by TSEM at days 3, 7, 14, and 21 after infection. On days 3 and 7, no spores or immature forms of the parasite were seen within MDM. On days 14 and 21, both spores and immature forms of the parasite were detected in parasitophorous vacuoles in the host cell cytoplasm. The parasitophorous vacuoles were more common at day 21. No microsporidia were detected in control uninfected MDM.
The replicating and mature forms of the parasite were similar to those seen in HEL cells, although two interesting observations were made at day 21 postinfection. First, a sporont with three nuclei was seen (Fig. 6A) . Second, a section through a sporoblast (Fig. 6B) , a form of the parasite that represents an early stage in the differentiation of the spore, showed the tubule to contain a dense core unlike the fuzzy ring seen in the tubule of the mature spore (Fig. 3B ). It appears that the inner fuzzy band of the mature spore tubule forms from a dense core. As with infected HEL cells, the parasite was seen in parasitophorous vacuoles with distinct septa separating spores of the parasite (Fig. 6C) .
16S rDNA gene sequencing. Alignment of the partial sequence of the 16S rDNA gene against the Entrez database showed high (ϳ96.9%) genetic homology with previously published sequences (26) of S. intestinalis (Entrez database accession number L19567). Other matches were obtained against the closely related microsporidial species E. hellem (ϳ87.3%) and Encephalitozoon cuniculi (ϳ85.7%). Previously published 16S rDNA sequences have shown a high level of genetic homology between Septata and Encephalitozoon species (23) .
DISCUSSION
This study presents the first report of the growth of S. intestinalis in vitro and is also the first report of the in vitro cultivation of a human microsporidian in macrophages.
The genus most commonly associated with disseminated microsporidiosis in AIDS patients is Encephalitozoon (18, 24) . The species of this genus (E. hellem and E. cuniculi) are morphologically identical (18) and have many features in common with the recently identified S. intestinalis (5) . However, a significant difference between Encephalitozoon spp. and S. intestinalis is the presence of septate material between spores of S. intestinalis within the parasitophorous vacuoles (5) .
In vivo morphological studies of S. intestinalis (5) indicate that features of this parasite are similar to those found in this study. The previously reported spores of S. intestinalis were suspended in a honeycomb array of septate material with a spore in each chamber, similar to the spores of the parasite seen in this study. S. intestinalis spores are reportedly about 2 by 1.2 m in size, which compares favorably with the size of the spores reported in this study (1.8 by 0.9 m). S. intestinalis spores have four to seven (but usually five) turns of the polar tubule, again similar to our findings (four to five turns). Binucleated forms of the sporont stage of S. intestinalis have nuclei that do not abut each other; similarly, the sporont nuclei (5) reported bi-and tetranucleated forms of the sporont stage; in this study, bi-and trinucleated forms of the parasite were noted. Although a tetranucleated form was not seen, this may simply relate to the low probability of having all four nuclei in the one plane of section. On the basis of this evidence, it is reasonable to conclude that the species in this report is S. intestinalis. The species responsible for disseminated microsporidiosis may also be separated at a genetic level. Nucleotide sequencing of the well-conserved 16S rDNA gene of E. cuniculi and E. hellem has revealed high sequence similarity, although there are significant differences to allow a distinction between these closely related organisms (23) . The subsequently published sequence data for S. intestinalis (26) show high similarity but features distinct from those of E. cuniculi and E. hellem. Comparison of the sequence of 16S rDNA of the isolate described in this study with previously published sequences (23, 26) confirms the morphological observation that the parasite grown is S. intestinalis.
At present the mechanism of dissemination of microsporidia in persons with advanced HIV disease is unclear. This study, taken with the findings of Cali et al. (5) and Ryan et al. (17) , supports the view that dispersion of the parasite occurs via macrophages. Cali et al. (5) have previously noted the presence of S. intestinalis in macrophages of the lamina propria of infected gut. The presence of the parasite in cells from NPA which morphologically resemble macrophages has also been demonstrated (17) . In this study microsporidia causing disseminated disease in a patient with advanced HIV infection were clearly shown to replicate within macrophages in vitro. These findings suggest that microsporidia can become disseminated through infection of macrophages which migrate to a variety of tissues in the host.
The process by which macrophages disseminate microsporidia in individuals with advanced HIV disease is unclear. It is well established that macrophage function is altered by infection with HIV (3, 9) , and this is probably an important factor in the process of dissemination. Baldwin et al. (2) have shown that HIV-infected macrophages are less capable of killing Candida pseudotropicalis than uninfected macrophages. It is possible that microsporidia are also less likely to be killed in HIVinfected macrophages than in uninfected macrophages.
The definitive diagnosis of disseminated microsporidiosis requires the classification of microsporidia to species level in a number of sites in the infected host. In this study the microsporidia isolated from NPA were shown to be S. intestinalis after culture in HEL cells and MDM. TSEM of a duodenum biopsy taken about 1 month after the collection of the NPA from the patient revealed identical parasitophorous vacuoles with spores separated by distinct septa (unpublished observation). Thus, at the very least, S. intestinalis has been shown to be present in the gut and the NPA of this patient. Taken with the light microscopy findings of spores in the NPA, feces, and urine of this individual (see Materials and Methods), this report provides compelling evidence in support of a case of disseminated microsporidiosis.
The successful in vitro growth of S. intestinalis will provide antigen for the development of immunological assays for diagnostic and epidemiological studies and also permit better evaluation of drug strategies. In addition, the growth of the parasite in macrophages will enable a better understanding of the nature of disseminated microsporidiosis. 
